ESR1 and cancer: CD146-positive CAFs retain ER expression in ER-positive BC cells, as well as estrogen responsiveness and tamoxifen sensitivity, whereas CD146-negative CAFs inhibit cancer cell responses to tamoxifen, resulting in poor prognosis [131].